Targeted discovery of gut microbiome-remodeling compounds for the treatment of systemic inflammatory response syndrome/Experiment 21/Signature 2
From BugSigDB
Needs review
Source: Figure 8C
Description: Abundance comparison of key genera between SIRS patients and healthy volunteers
Abundance in Group 1: decreased abundance in P (Patients with SIRS)
| NCBI | Quality Control | Links |
|---|---|---|
| Bifidobacterium | ||
| Streptococcus | ||
| Blautia | ||
| Fusicatenibacter | ||
| Faecalibacterium | ||
| Dorea | ||
| Agathobacter | ||
| Romboutsia |
Revision editor(s): Ifeanyisam
